{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:42:59Z","timestamp":1792784579253,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Takeda Pharmaceuticals"},{"name":"Newcells Biotech"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.tox.2020.152535","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T11:21:30Z","timestamp":1593688890000},"page":"152535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Freshly isolated primary human proximal tubule cells as an in vitro model for the detection of renal tubular toxicity"],"prefix":"10.1016","volume":"442","author":[{"given":"Piyush","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Git","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Pye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Takai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Wagoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2020.152535_bib0005","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1681\/ASN.2015010060","article-title":"A quantitative approach to screen for nephrotoxic compounds in vitro","volume":"27","author":"Adler","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2020.152535_bib0010","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1124\/dmd.118.082958","article-title":"Emerging kidney models to investigate metabolism, transport, and toxicity of drugs and xenobiotics","volume":"46","author":"Bajaj","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2020.152535_bib0015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tox.2020.152535_bib0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.taap.2008.09.018","article-title":"Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling","volume":"233","author":"Brown","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2020.152535_bib0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1471-0528.2001.00128.x","article-title":"Evaluation of a clinical test. II: assessment of validity","volume":"108","author":"Chien","year":"2001","journal-title":"BJOG Int. J. Obstet. Gy."},{"key":"10.1016\/j.tox.2020.152535_bib0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yrtph.2018.04.018","article-title":"A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans","volume":"96","author":"Clark","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2020.152535_bib0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tox.2020.152535_bib0040","doi-asserted-by":"crossref","first-page":"91a","DOI":"10.1016\/S0735-1097(85)80467-8","article-title":"Digitalis cardiotoxicity","volume":"5","author":"Fisch","year":"1985","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tox.2020.152535_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.tox.2020.152535_bib0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0300-483X(97)03661-5","article-title":"Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys","volume":"120","author":"Henry","year":"1997","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2020.152535_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.ajkd.2010.09.024","article-title":"Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma","volume":"57","author":"Herrington","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tox.2020.152535_bib0060","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2016060606","article-title":"Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity","volume":"28","author":"Hori","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2020.152535_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.148","article-title":"Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells","volume":"3","author":"Huang","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.tox.2020.152535_bib0070","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1039\/c3ib40049b","article-title":"Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment","volume":"5","author":"Jang","year":"2013","journal-title":"Integr. Biol. (Camb)"},{"key":"10.1016\/j.tox.2020.152535_bib0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-012-1163-2","article-title":"The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule","volume":"464","author":"Jenkinson","year":"2012","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tox.2020.152535_bib0080","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tox.2020.152535_bib0085","doi-asserted-by":"crossref","first-page":"12337","DOI":"10.1038\/srep12337","article-title":"Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods","volume":"5","author":"Kandasamy","year":"2015","journal-title":"Sci. Rep. - UK"},{"key":"10.1016\/j.tox.2020.152535_bib0090","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1248\/bpb.33.1867","article-title":"Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity","volume":"33","author":"Katsuda","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tox.2020.152535_bib0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s13181-012-0248-9","article-title":"4-aminopyridine toxicity: a case report and review of the literature","volume":"8","author":"King","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.tox.2020.152535_bib0100","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2125.2012.04440.x","article-title":"A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects","volume":"75","author":"Koteff","year":"2013","journal-title":"Brit. J. Clin. Pharmaco."},{"key":"10.1016\/j.tox.2020.152535_bib0105","doi-asserted-by":"crossref","first-page":"12491","DOI":"10.1073\/pnas.211291398","article-title":"Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia","volume":"98","author":"Kozyraki","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.tox.2020.152535_bib0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1039\/c3tx50042j","article-title":"An in vitro method for the prediction of renal proximal tubular toxicity in humans","volume":"2","author":"Li","year":"2013","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2020.152535_bib0115","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/mp400637s","article-title":"Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells","volume":"11","author":"Li","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2020.152535_bib0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/toxsci\/kfr339","article-title":"Evaluation of drugs with specific organ toxicities in organ-specific cell lines","volume":"126","author":"Lin","year":"2012","journal-title":"Toxicol. Sci. \u2013 UK"},{"key":"10.1016\/j.tox.2020.152535_bib0125","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1124\/dmd.118.082966","article-title":"Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 1352 drug compounds","volume":"46","author":"Lombardo","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2020.152535_bib0130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/psp4.12400","article-title":"Translational assessment of drug-induced proximal tubule injury using a kidney microphysiological system","volume":"8","author":"Maass","year":"2019","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.tox.2020.152535_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtn.2016.11.006","article-title":"Inhibition of EGF uptake by nephrotoxic antisense drugs in vitro and implications for preclinical safety profiling","volume":"6","author":"Moisan","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tox.2020.152535_bib0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2017.09.006","article-title":"Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: the IQ consortium nonclinical to clinical translational database","volume":"334","author":"Monticello","year":"2017","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.tox.2020.152535_bib0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.tox.2020.152535_bib0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphar.2014.00248","article-title":"The role of drug transporters in the kidney: lessons from tenofovir","volume":"5","author":"Moss","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tox.2020.152535_bib0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2020.152535_bib0160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1208\/s12248-016-9871-8","article-title":"A human renal proximal tubule cell line with stable organic anion transporter 1 and 3 expression predictive for antiviral-induced toxicity","volume":"18","author":"Nieskens","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.tox.2020.152535_bib0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxlet.2012.05.012","article-title":"Role of megalin and the soluble form of its ligand RAP in Cd-metallothionein endocytosis and Cd-metallothionein-induced nephrotoxicity in vivo","volume":"212","author":"Onodera","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2020.152535_bib0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.vascn.2016.04.007","article-title":"Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes","volume":"81","author":"Pfeiffer","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tox.2020.152535_bib0175","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.116.072066","article-title":"Abundance of drug transporters in the human kidney cortex as quantified by quantitative targeted proteomics","volume":"44","author":"Prasad","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2020.152535_bib0180","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2020.152535_bib0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/toxsci\/kfz021","article-title":"A systems toxicology approach for the prediction of kidney toxicity and its mechanisms in vitro","volume":"169","author":"Ramm","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152535_bib0190","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1074\/jbc.M109959200","article-title":"Megalin deficiency offers protection from renal aminoglycoside accumulation","volume":"277","author":"Schmitz","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2020.152535_bib0195","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","article-title":"Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in vitro assays","volume":"147","author":"Shah","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152535_bib0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.116.072264","article-title":"Organic anion transporter 2: an enigmatic human solute carrier","volume":"45","author":"Shen","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2020.152535_bib0205","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00204-018-2284-y","article-title":"A novel multi-parametric high content screening assay in ciPTEC-OAT1 to predict drug-induced nephrotoxicity during drug discovery","volume":"92","author":"Sj\u00f6gren","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2020.152535_bib0210","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1046\/j.1523-1755.1999.00789.x","article-title":"Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity","volume":"56","author":"Takeda","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2020.152535_bib0215","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.2217\/fon.15.47","article-title":"Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management","volume":"11","author":"Tartarone","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.tox.2020.152535_bib0220","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1021\/jm900403j","article-title":"Physicochemical determinants of human renal clearance","volume":"52","author":"Varma","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2020.152535_bib0225","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tox.2020.152535_bib0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1208\/s12248-018-0248-z","article-title":"Nephrotoxicity and kidney transport assessment on 3D perfused proximal tubules","volume":"20","author":"Vormann","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.tox.2020.152535_bib0235","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ckj\/sfv041","article-title":"Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series","volume":"8","author":"Waheed","year":"2015","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.tox.2020.152535_bib0240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.kint.2016.06.011","article-title":"Development of a microphysiological model of human kidney proximal tubule function","volume":"90","author":"Weber","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2020.152535_bib0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.tiv.2014.10.019","article-title":"Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir","volume":"29","author":"Zhang","year":"2015","journal-title":"Toxicol. In Vitro"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X20301748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X20301748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:43:41Z","timestamp":1759535021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X20301748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":49,"alternative-id":["S0300483X20301748"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2020.152535","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Freshly isolated primary human proximal tubule cells as an in vitro model for the detection of renal tubular toxicity","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2020.152535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"152535"}}